SI01-06 - Afirma Molecular Testing: Unique Situations and New Prognostic Development

Sunday, June 14, 2026

2:30 PM - 3:30 PM CT

Location: ENDOExpo; Theater 1

Speaker(s)

Joshua Paul Klopper, MD

Medical Director, Endocrinology
Veracyte, Inc.
Denver, CO, United States
TP

Theodora Pappa, MD, PhD

Associate Physician
Brigham and Women's Hospital
Winchester, MA, United States
AB

Athanasios Bikas, MD-PhD

BRIGHAM AND WOMEN'S HOSPITAL
Boston, United States

Disclosure(s):

Joshua Paul Klopper, MD: Veracyte Inc.: Employee (any industry) ()

In this presentation, Drs. Anthanasios Bikas and Theodora Pappa from Brigham and Women's Hospital will join Dr. Joshua Klopper, Medical Director of Endocrinology at Veracyte, and will describe how Afirma's whole-exome molecular analysis provides accurate and reproducible results to help in thyroid nodule management, and represents a platform for novel research opportunities.